| MR编号 | NL/H/5911/001 |
|---|
| 药品名称 | Emtricitabin/Tenofovirdisoproxil Tillomed 200 mg/245 mg Filmtabletten |
|---|
| 活性成分 | - Emtricitabine 200.0 mg
- Tenofovir disoproxil fumarate 300.0 mg
|
|---|
| 剂型 | Film-coated tablet |
|---|
| 上市许可持有人 | Tillomed Pharma GmbH
Mittelstraße 5/5a
12529 Schönefeld
Germany |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Denmark (DK)
Emtricitabin/Tenofovirdisoproxil Tillomed - Ireland (IE)
- Austria (AT)
Emtricitabin/Tenofovirdisoproxil Tillomed 200 mg/245 mg Filmtabletten - Spain (ES)
- Sweden (SE)
- Norway (NO)
Emtricitabin/Tenofovirdisoproxil Tillomed - Finland (FI)
- Poland (PL)
Emtricitabine +Tenofovir disoproxil Tillomed - Romania (RO)
Emtricitabină/tenofovir disoproxil Tillomed 200 mg/245 mg comprimate filmate
|
|---|
| 许可日期 | 2020/04/16 |
|---|
| 最近更新日期 | 2024/12/17 |
|---|
| 药物ATC编码 | - J05AR03 tenofovir disoproxil and emtricitabine
|
|---|
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：[not specified]
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|